41
Efficacy and Tolerability of Delamanid, Linezolid, Pyrazinamide and Levofloxacin
Condition(s):Tuberculosis Multi Drug Resistant ActiveLast Updated:September 11, 2017Withdrawn
Isoniazid, INH Or H: 63 Clinical Trials, Page 5 of 7
Hide Studies Not Open or Pending
42
Shortening Treatment by Advancing Novel Drugs
Condition(s):Tuberculosis, Pulmonary, Drug Sensitive; Tuberculosis, Pulmonary, Multi Drug-resistantLast Updated:March 26, 2019Completed
43
Safety and Efficacy of High Dose Rifampicin in Tuberculosis (TB)-HIV Co-infected Patients on Efavirenz- or Dolutegravir-based Antiretroviral Therapy
Condition(s):TuberculosisLast Updated:July 12, 2019Unknown status
44
The Effect of 18-month Regimen Containing 6 Anti-tuberculosis Drugs for Patients With MDR-TB
Condition(s):Multi-drug Resistant TuberculosisLast Updated:May 28, 2019Unknown status
45
Closing -TB GAPs – for People Living With HIV: TB Guidance for Adaptable Patient-Centered Service
Condition(s):Tuberculosis; HIV Coinfection; Tuberculosis InfectionLast Updated:April 22, 2022Not yet recruiting
46
Efficacy and Tolerability of Bedaquiline, Delamanid, Levofloxacin, Linezolid, and Clofazimine to Treat MDR-TB
Condition(s):Tuberculosis, Multidrug-ResistantLast Updated:May 5, 2022Recruiting
47
Preventive Treatment Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection
Condition(s):HIV Infections; TuberculosisLast Updated:November 2, 2021Completed
48
Trial of High-Dose Rifampin in Patients With TB
Condition(s):TuberculosisLast Updated:November 20, 2017Completed
49
A New Treatment for Primary Smear-positive Pulmonary Tuberculosis With Interleukin-2
Condition(s):Tuberculosis, PulmonaryLast Updated:February 23, 2021Recruiting
50
Protecting Households On Exposure to Newly Diagnosed Index Multidrug-Resistant Tuberculosis Patients
Condition(s):Tuberculosis, MDRLast Updated:May 6, 2022Recruiting